Patients Patients Patients Patients
Group 1 (n=151) Group 2 (n=72) Group 2 (n=72) Group 1+2 (Adherent) (n=223) Group 3 (Non-adherent) (n=104) Group 3 (Non-adherent) (n=104)
P*
Age, mean Age, mean 36.5±11.3 36.5±11.3 32.9±10.7 35.4±11.2 35.4±11.2 34.3±10.8 NS
Sex, n (%) Women Men Sex, n (%) Women Men 90 (59.6) 61 (40.4) 90 (59.6) 61 (40.4) 45 (62.5) 27 (37.5) 135 (60.5) 88 (39.5) 135 (60.5) 88 (39.5) 69 (66.3) 35 (33.7)
NS
Diagnosis of respiratory diseases, n (%) Allergic rhinitis Allergic asthma Allergic rhinitis and asthma Diagnosis of respiratory diseases, n (%) Allergic rhinitis Allergic asthma Allergic rhinitis and asthma 111 (73.5) 0 (0) 40 (26.5) 111 (73.5) 0 (0) 40 (26.5) 56 (77.8) 0 (0) 16 (22.2) 167 (74.9) 0 (0) 56 (25.1) 167 (74.9) 0 (0) 56 (25.1) 73 (70.2) 1 (1) 30 (28.8) NS NS NS
Type of allergen, n (%) HDM Weed pollens Grass pollens Grass and cereal pollens Grass and weed pollens Grass, cereal and weed pollens Cat Alternia alternata HDM and weed pollens HDM and grass pollens HDM, grass and cereal pollens Cat and grass pollens HDM and cat Any pollen with or without another concomitant allergen Duration of immunotherapy (month) Median (IQR 25-75) Type of allergen, n (%) HDM Weed pollens Grass pollens Grass and cereal pollens Grass and weed pollens Grass, cereal and weed pollens Cat Alternia alternata HDM and weed pollens HDM and grass pollens HDM, grass and cereal pollens Cat and grass pollens HDM and cat Any pollen with or without another concomitant allergen Duration of immunotherapy (month) Median (IQR 25-75) 87 (57.6) 24 (15.9) 9 (6.0) 10 (6.6) 2 (1.3) 1 (0.7) 1 (0.7) 1 (0.7) 6 (4.0) 1 (0.7) 5 (3.3) 2 (1.3) 2 (1.3) 60 (39.7) 24 (9.5-37) 87 (57.6) 24 (15.9) 9 (6.0) 10 (6.6) 2 (1.3) 1 (0.7) 1 (0.7) 1 (0.7) 6 (4.0) 1 (0.7) 5 (3.3) 2 (1.3) 2 (1.3) 60 (39.7) 24 (9.5-37) 55 (76.4) 6 (8.3) 2 (2.8) 6 (8.3) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (2.8) 1 (1.4) 0 (0) 0 (0) 17 (23.6) 20 (10-36) 142 (63.7) 30 (13.5) 11 (4.9) 16 (7.2) 2 (0.9) 1 (0.4) 1 (0.4) 1 (0.4) 6 (2.7) 3 (1.3) 6 (2.7) 2 (0.9) 2 (0.9) 77(34.5) 21 (10-36) 142 (63.7) 30 (13.5) 11 (4.9) 16 (7.2) 2 (0.9) 1 (0.4) 1 (0.4) 1 (0.4) 6 (2.7) 3 (1.3) 6 (2.7) 2 (0.9) 2 (0.9) 77(34.5) 21 (10-36) 82 (78.8) 8 (7.7) 2 (1.9) 3 (2.9) 0 (0) 0 (0) 1 (1.0) 0 (0) 1 (1.0) 3 (2.9) 2 (1.9) 0 (0) 2 (1.9) 19 (18.3) 24 (12-34) 0.003 NS NS NS NS NS NS NS NS NS NS NS NS 0.003 NS
Cigarette, n (%) User Nonuser Cigarette, n (%) User Nonuser 30 (19.9) 121 (80.1) 30 (19.9) 121 (80.1) 14 (19.4) 58 (80.6) 44 (19.7) 179 (80.3) 44 (19.7) 179 (80.3) 25 (24) 79 (76)
NS
Level of education, n (%) Not educated Primary school Intermediate school High school University Level of education, n (%) Not educated Primary school Intermediate school High school University 1 (0.6) 24 (15.8) 15 (9.9) 42 (27.8) 69 (45.6) 1 (0.6) 24 (15.8) 15 (9.9) 42 (27.8) 69 (45.6) 0 6 (8.3) 9 (12.5) 17 (23.6) 40 (55.5) 1 (0.4) 30 (13.4) 24 (10.7) 59 (26.4) 109 (48.8) 1 (0.4) 30 (13.4) 24 (10.7) 59 (26.4) 109 (48.8) 2 (1.9) 19 (18.2) 4 (3.8) 23 (22.1) 56 (53.8) NS NS NS NS NS
Occupation, n (%) Blue collar workers White collar workers Government employee Healthcare workers Tradesmen Students Retired Housewives Unemployed Occupation, n (%) Blue collar workers White collar workers Government employee Healthcare workers Tradesmen Students Retired Housewives Unemployed 39 (25.8) 23 (15.2) 20 (13.2) 5 (3.3) 3 (2.0) 15 (9.9) 4 (2.6) 38 (25.2) 4 (2.6) 39 (25.8) 23 (15.2) 20 (13.2) 5 (3.3) 3 (2.0) 15 (9.9) 4 (2.6) 38 (25.2) 4 (2.6) 11 (15.3) 12 (16.7) 7 (9.7) 4 (5.6) 3 (4.2) 13 (18.1) 1 (1.4) 18 (25) 3 (4.2) 50 (22.4) 35 (15.6) 27 (12.1) 9 (4.0) 6 (2.6) 28 (12.5) 5 (2.2) 56 (25.1) 7 (3.1) 50 (22.4) 35 (15.6) 27 (12.1) 9 (4.0) 6 (2.6) 28 (12.5) 5 (2.2) 56 (25.1) 7 (3.1) 16 (15.4) 17 (16.3) 13 (12.5) 6 (5.8) 3 (2.9) 14 (13.5) 1 (1.0) 29 (27.9) 5 (4.8) NS NS NS NS NS NS NS NS NS
Transportation options for reaching the hospital, n (%) Public transport Private vehicle or on foot Transportation options for reaching the hospital, n (%) Public transport Private vehicle or on foot 63 (41.7) 88 (58.3) 63 (41.7) 88 (58.3) 40 (55.6) 32 (44.4) 103 (46.2) 120 (53.8) 103 (46.2) 120 (53.8) 64 (61.5) 40 (38.5)
0.01
Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups Group 1 = routine intervals; Group 2 = extended intervals (<2 months); Group 3 = extended intervals (≥2 months); NS = non-significant; HDM = house dust mite * The p-value was calculated between adherent and non-adherent groups